These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26729430)

  • 1. Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer.
    Dowsett M; Lønning PE; Davidson NE
    J Clin Oncol; 2016 May; 34(14):1580-3. PubMed ID: 26729430
    [No Abstract]   [Full Text] [Related]  

  • 2. Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.
    Tan SH; Wolff AC
    Clin Breast Cancer; 2007 Feb; 7(6):455-64. PubMed ID: 17386122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
    Suh KJ; Kim SH; Lee KH; Kim TY; Kim YJ; Han SW; Kang E; Kim EK; Kim K; No JH; Han W; Noh DY; Lee M; Kim HS; Im SA; Kim JH
    Cancer Res Treat; 2017 Oct; 49(4):1153-1163. PubMed ID: 28253566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant endocrine therapy in premenopausal women with breast cancer.
    González Martín A; de la Cruz S; Márquez R
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():43-7. PubMed ID: 20711666
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.
    Caruso M; Castiglione G; Aiello R; Alí M; Chiarenza M; Dimarco R; Fallica G; Di Leo MG; Sanó MV; Taibi E; Zacchia A; Miano E; Caruso F
    Future Oncol; 2015; 11(23):3109-12. PubMed ID: 26544787
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
    ; Cuzick J; Ambroisine L; Davidson N; Jakesz R; Kaufmann M; Regan M; Sainsbury R
    Lancet; 2007 May; 369(9574):1711-23. PubMed ID: 17512856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gonadotropin-Releasing-Hormone Analogues in the Treatment of Breast Cancer.
    Rossi L; Pagani O
    J Womens Health (Larchmt); 2018 Apr; 27(4):466-475. PubMed ID: 28926289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHRH-agonist versus chemotherapy in premenopausal breast cancer?
    Klijn JG
    Eur J Cancer; 2002 Nov; 38 Suppl 6():S45-6. PubMed ID: 12409071
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
    Klijn JG; Blamey RW; Boccardo F; Tominaga T; Duchateau L; Sylvester R;
    J Clin Oncol; 2001 Jan; 19(2):343-53. PubMed ID: 11208825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting highlights: International consensus panel on the treatment of primary breast cancer.
    Love RR
    J Clin Oncol; 2002 Apr; 20(7):1955-6; author reply 1956-7. PubMed ID: 11919263
    [No Abstract]   [Full Text] [Related]  

  • 11. Aromatase inhibitors might be more effective when they are given 2-3 months later after the administration of luteinizing hormone-releasing hormone agonists in younger premenopausal breast cancer patients.
    Altundag K
    J BUON; 2018; 23(6):1928. PubMed ID: 30610824
    [No Abstract]   [Full Text] [Related]  

  • 12. Which is the appropriate adjuvant endocrine therapy for premenopausal patients with breast cancer?
    Petrelli F; Barni S
    Clin Breast Cancer; 2015 Jun; 15(3):169-70. PubMed ID: 25600162
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
    Briest S; Wolff AC
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1243-53. PubMed ID: 17892424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives.
    Love RR
    Oncology (Williston Park); 2010 Apr; 24(4):322-7. PubMed ID: 20464842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment.
    Gram IT; Ursin G; Spicer DV; Pike MC
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1117-20. PubMed ID: 11700258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience.
    Barbie TU; Ma C; Margenthaler JA
    Ann Surg Oncol; 2015 Nov; 22(12):3861-5. PubMed ID: 25783678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives.
    Del Mastro L; Levaggi A; Giraudi S; Pronzato P
    Cancer Treat Rev; 2011 May; 37(3):208-11. PubMed ID: 20724078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
    Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
    Parton M; Smith IE
    J Clin Oncol; 2008 Feb; 26(5):745-52. PubMed ID: 18258982
    [No Abstract]   [Full Text] [Related]  

  • 20. [LH-RH analogue for the treatment in premenopausal, receptor-positive breast cancer].
    Sano M; Makino H
    Nihon Rinsho; 2000 Apr; 58 Suppl():328-33. PubMed ID: 11026014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.